[Advances and perspective in clinical research on breast cancer].
Xu
Bing-He
BH
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000517:prevention & control / Q000556:secondary / Q000601:surgery; D017024:Chemotherapy, Adjuvant / Q000379:methods; D055088:Early Detection of Cancer / Q000379:methods; D005260:Female; D006801:Humans; D013629:Tamoxifen / Q000627:therapeutic use*; D043823:Taxoids / Q000627:therapeutic use*
D018931:Antineoplastic Agents, Hormonal; D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D013629:Tamoxifen